2002
DOI: 10.1016/s0891-5849(02)01137-1
|View full text |Cite
|
Sign up to set email alerts
|

Uptake and metabolism of epicatechin and its access to the brain after oral ingestion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
210
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 342 publications
(223 citation statements)
references
References 28 publications
12
210
1
Order By: Relevance
“…For example, EGCG has been shown to reducing H 2 O 2 and ferrous ion-induced lipid peroxidation in gerbil brain homogenates and to inhibit lipid peroxidation in kidney and liver tissue after induction of oxidative stress with bromotrichloromethane (36, 37). These compounds easily reach brain tissue after oral ingestion to initiate and potentially reduce oxidative stress and inflammation, making them extremely attractive therapeutic compounds, given the lack of a neuronal morphophysiological barrier to GTP access (38,39). The findings presented in this study provide the first indication that oral GTP administration attenuates not only the oxidative and inflammatory mechanisms associated with IH during sleep but also prevents IH-induced spatial learning deficits in the rat.…”
Section: Discussionmentioning
confidence: 67%
“…For example, EGCG has been shown to reducing H 2 O 2 and ferrous ion-induced lipid peroxidation in gerbil brain homogenates and to inhibit lipid peroxidation in kidney and liver tissue after induction of oxidative stress with bromotrichloromethane (36, 37). These compounds easily reach brain tissue after oral ingestion to initiate and potentially reduce oxidative stress and inflammation, making them extremely attractive therapeutic compounds, given the lack of a neuronal morphophysiological barrier to GTP access (38,39). The findings presented in this study provide the first indication that oral GTP administration attenuates not only the oxidative and inflammatory mechanisms associated with IH during sleep but also prevents IH-induced spatial learning deficits in the rat.…”
Section: Discussionmentioning
confidence: 67%
“…Another criterion of STAIR is that the drug must cross the blood-brain barrier. Available evidence indicates that EC does cross the blood-brain barrier (Abd El Mohsen et al, 2002), as epicatechin glucuronide and 3 0 -O-methyl epicatechin glucuronide have been observed in rat brain for up to 10 days after oral administration of EC (van Praag et al, 2007). Furthermore, after transient ischemia, the blood-brain barrier is likely to be more permeable, especially in the surrounding ischemic region.…”
Section: Discussionmentioning
confidence: 99%
“…The tea flavanol EGCG has been reported to access the brain after oral administration to mice [166]. Furthermore, oral ingestion of pure epicatechin resulted in the detection of epicatechin glucuronide and 3 0 -O-methyl-epicatechin glucuronide in rat brain tissue [3]. Anthocyanidins have also been detected in the brain after oral administration [53,168], with several anthocyanidins being identified in different regions of rat brain after the animals were fed with blueberry [12].…”
Section: Flavonoid Metabolism and Access To The Brainmentioning
confidence: 99%